Company / CapEx per Share
Amphstar Pharmaceuticals, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.73
FY2025
5-year range
$0.50 / $0.85
FY2021-FY2025
Trend
-14.2%
vs FY2024
Sector context
#16 of 192
Health Care
What the data says
Among 192 Health Care companies, Amphstar Pharmaceuticals, Inc. is in the top 8% for capex per share. CapEx per Share has fluctuated over the past 10 years, ranging from $0.47 in FY2016 to $1.00 in FY2018.
Based on SEC 10-K filings.
0.73 in FY2025 with a 5-year CAGR of +0.2%. Top quartile in the Health Care sector.
Declined from $0.79 to $0.73 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 192This company $0.73 Sector average $3.54
▼
-79.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 14.2% year-over-year.
- Ranks #16 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2018.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.73 | -14.2% |
| FY2024 | $0.85 | +7.6% |
| FY2023 | $0.79 | +57.5% |
| FY2022 | $0.50 | -12.9% |
| FY2021 | $0.58 | -20.5% |
| FY2020 | $0.73 | -18.4% |
| FY2019 | $0.89 | -11.2% |
| FY2018 | $1.00 | +32.3% |
| FY2017 | $0.76 | +60.4% |
| FY2016 | $0.47 | +32.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026